Delivery Order SPE2DB24D2205-SPE2DB26FDSLQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,987.51 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100 count). This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,552.79 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100-count unit). This competitively awarded, firm fixed-price contract is not set-aside and was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $1,376.87 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg capsules (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,266.20 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg in a quantity of 100 capsules. This competitive award, effective September 25, 2025, with completion targeted for September 26, 2025, was issued on a firm fixed-price basis without any set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count unit). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, valued at $3,375.52 and scheduled for completion by June 17, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and distribution...
- The Defense Logistics Agency awarded a delivery order valued at $1,006.80 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg in a quantity of 100 capsules. The contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,301.28 for Methylphenidate ER(LA) 10mg capsules (100-count) on September 23, 2025, with completion scheduled for September 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Methylphenidate ER(LA) 20mg capsules (100 count) with a ceiling value of $1,421.35. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and running through December 2026. The delivery order was competitively awarded with no set-aside designation and is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,130.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 30mg capsules (100-count units). This contract award, executed on August 4, 2025, with completion targeted for August 5, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Methylphenidate ER(LA) 20mg in quantities of 100 capsules. This is a firm fixed price delivery order with a ceiling value of $2,169.84 and an ultimate completion date of September 19, 2025. The contract was competitively awarded with no set-aside designation, and performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSLQDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,628.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100-count units). The order, issued on October 17, 2025, with completion scheduled for October 20, 2025, represents a non-competitive, non-set-aside procurement under the company's existing Indefinite Delivery Contract with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is executed under AmerisourceBergen's comprehensive $999.999 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and provides global pharmaceutical support for military healthcare programs worldwide. The contract vehicle enables the company to supply a diverse range of pharmaceutical products, including brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The methylphenidate order fulfills federal demand for this FDA-controlled ADHD medication, supporting treatment requirements across Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/17/25 |